Tag: prostate cancer
Once more into the screening breach: The New York Times did not kill your patient
Dr. George Lombardi thinks that he could have saved a patient from dying of prostate cancer if a prostate specific antigen test had been done. Is he right? Probably not.
Prostate Cancer Dilemmas: To Test or Not to Test, To Cut or Not to Cut
Diagnosing prostate cancer based on the prostate-specific antigen (PSA) test is a tricky proposition. The cancer itself can be slow-growing, and the treatment harmful. Medicine is complicated, particularly when it comes to cancer screening.
Cancer prevention: The forgotten stepchild of cancer research?
The New York Times has been periodically running a series about the “40 years’ war” on cancer, with most articles by Gina Kolata. I’ve touched on this series before, liking some parts of it, while others not so much. In particular, I criticized an article one article that I thought to be so misguided about how the NIH grant system leads researchers...
The cancer screening kerfuffle erupts again: “Rethinking” screening for breast and prostate cancer
I see that the kerfuffle over screening for cancer has erupted again to the point where it’s found its way out of the rarified air of specialty journals to general medical journals and hence into the mainstream press. Over the last couple of weeks, articles have appeared in newspapers such as the New York Times and Chicago Tribune, radio networks like NPR,...
PSA – To Screen or Not to Screen
Is the prostate specific antigen (PSA) test worth taking? It's, like, really complicated.